Al Hammadi (4007) Financial Ratio Screen
Track 4007 screening changes
Get an email when this stock's published screening status or underlying ratios change.
MSCI new-inclusion financial-ratio snapshot
4007 financial screening at a glance
Calculation date: 2026-08-31. Financial period used: December 2024. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.
Independent method comparison
What the available screens say
How MSCI, FTSE and S&P-style screens differThe request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.
Business activity evidence
Activity assessment in progress
The supplied classification (Medical Care Facilities) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.
Revenue segments: Not yet checked against an SEC annual filing.
Profile description reviewed: Al Hammadi Holding Company, a healthcare group, provides healthcare services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It engages in the sale of pharmaceutical products; and provides medical services. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in August 2022. Al Hammadi Holding Company was founded in 1985 and is based in Riyadh, the Kingdom of Saudi Arabia.
Sources to verify: Secondary company profile and classification · Issuer website
A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.
Published-ratio reproductions (not certifications)
The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| MSCI | 11.5% / 30% | 9.3% / 30% | 25.6% / 30% | 0.53% / 5% | FINANCIAL SCREEN PASSED* |
| FTSE | 11.5% / 33% | 9.3% / 33% | 25.6% / 50% | 0.53% / 5% | FINANCIAL SCREEN PASSED* |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | 18.7% | |
| Net Margin | 19.6% | |
| Return on Equity (ROE) | 12.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $464M |
| Free Cash Flow | $250M |
| Total Debt | $304M |
| Debt-to-Equity | 14.6 |
| Total Assets | $2.7B |
Price & Trading
| Last Close | SAR 25.72 |
| 50-Day MA | SAR 25.98 |
| 200-Day MA | SAR 31.23 |
| Avg Volume | 335K |
| Beta | 0.2 |
|
52-Week Range
SAR 23.42
| |
Financial data provenance and verification
The displayed fields were imported from yfinance on 2026-03-29 for the financial period December 2024. This is a secondary data feed and can differ from amended or newly filed statements.
- Issuer website — use its investor-relations filings to verify the figures.
- Field mapping, formulas and limitations.
Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.
About Al Hammadi (4007)
Al Hammadi Holding Company, a healthcare group, provides healthcare services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It engages in the sale of pharmaceutical products; and provides medical services. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in August 2022. Al Hammadi Holding Company was founded in 1985 and is based in Riyadh, the Kingdom of Saudi Arabia.
Popular halal stock checks
Explore other frequently viewed automated stock screens and compare the available financial ratios.
Frequently Asked Questions
Is Al Hammadi (4007) halal to invest in?
The current automated result is Financial screen passed; activity assessment pending. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.
What is Al Hammadi's debt ratio?
Al Hammadi's debt ratio is 11.5% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.
What are Al Hammadi's key financial metrics?
Al Hammadi has a market capitalization of SAR 4125M in its listing currency, trailing P/E ratio of 15.5, and revenue of $1.2B. The company maintains a gross margin of 100.0% and a net margin of 19.6%. Return on equity stands at 12.3%.
How often is the screening data updated?
Calculation date: 2026-08-31. Financial period: December 2024. These dates are shown separately because regenerating this page does not refresh the underlying data.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.